Julio- Septiembre 2005 N°24
DOI:10.70024 / ISSN 1317-987X
 
Buscar




Artículos
 
Introducción
Infecciones Respiratorias
Infecciones Diarreicas
Infecciones Hemorrágicas
Infecciones Nosocomiales
Infecciones por Estreptococos
Infecciones Micóticas
Infecciones Parasitarias
Misceláneos
Situaciones Especiales
Referencias



Microbiología
La Microbiología actualizada en Enfermedades Emergentes y Re-emergentes (Parte II)

Referencias

Bibliografía

  1. Taylor C. Micronutrients and Infectious Diseases: Integration of Basic Research into Clinical Studies. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 469.
  2. Hill A. Genetic Susceptibility to Infectious Diseases: Genomic Approaches. Abstracts. Int J Infect Dis. Cancún, 2004. p. 1.
  3. Cantor C. Surveying the Human Genome for Clues About Susceptibility to Infectious Diseases. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 454.
  4. Ochman H. Horizontal DNA Transfer as Inferred from Genome Sequences. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 509.
  5. Newport M. Genetic Susceptibility to Tuberculosis. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 454.
  6. Fischel N. Genetic Factors in Aminoglycoside Toxicity. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 520.
  7. Weber W. Toxicogenomics: History and Current Apllication. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 520.
  8. Crossman L, Cerdeno A, Parkhill J. The Bacteroides fragilis Genome Project. Abstracts. Int J Infect Dis. Cancún, 2004. p. 108.
  9. Raoult D. Free Amoeba as Trojan Horses for Pneumonia Pathogens. Abstracts. International Journal of Infectious Diseases. Cancún, 2004. p. 90.
  10. Valtonen M. The Role of Serology. Abstracts. 10th International Congress on Infectious Diseases. Singapur, 2002. p. 71.
  11. Curry A. The Role of Electron Microscopy. Abstracts. 10th International Congress on Infectious Diseases. Singapur, 2002. p. 71.
  12. Archer G. What does the Staphylococcal genome Tell Us that We Don?t Know Already?. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 471.
  13. Reiman D. The Role of Molecular Biology. Abstracts. 10th International Congress on Infectious Diseases. Singapur, 2002. p. 71.
  14. Smieja M, Mahony J, Goldsmith C, Chong S, Petrich A, Chernesky M. Replicate PCR Testing and Probit Analysis to Detect and Semi-Quantitate Chlamydia pneumoniae in Clinical Specimens. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 146.
  15. Vannulffel P, Cornu O, Bouyer M, Moreau M, Vandercam B, Gala J. Molecular Strategies for Identification of Infected Prostheses. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 146.
  16. Cunnigham M, Stull P, Clark K, Weisburg W, Summersgill J. Rapid Detection of Mycoplasma pneumoniae from Clinical Specimens by Transcription-Mediated Amplification. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 146.
  17. Nachamkin I. Sequence-Based Identification of Microbial Pathogens in the Clinical Microbiology Laboratory. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 448.
  18. Montenegro S, Fahey B, Hopper T, Dalovisio J. Real-time Nested PCR with SYBR Green I (SGI) Fluorescence: A Cost-effective and Simple Approach to Quantitative PCR for Infectious Pathogens. Abstracts. Int J Infect Dis. Cancún, 2004. p. 129.
  19. Hirokawa M, Yoshimuta T, Honda J, Etoh K, Fujiki R, Noda K, et al. Polymerase chain Reaction for the Detection of Bacteremia in Hematological Malignancies. Abstracts. Int J Infect Dis. Cancún, 2004. p. 215.
  20. Schreter I, Kristian P, Birosova E, Siegfred L, Jarcuska P, Pellova A. Prevalence of TT Virus Infection in Slovakia. Abstracts. Int J Infect Dis. Cancún, 2004. p. 111.
  21. Broeker M, Gniel D. Tick-borne Encephalitis (TBE) Virus Spreads Out in Europe: Consequences for Travellers from Abroad. Abstracts. Int J Infect Dis. Cancún, 2004. p. 113.
  22. Rector A, Tachezy R, Ranst M. A Novel Sequence-independent Strategy for Amplification of Circular DNA Virus Genomes Using Multiply-primed Rolling Circle Amplification (RCA). Abstracts. Int J Infect Dis. Cancún, 2004. p. 41.
  23. Gismondo M, Saco L. Use of Genomics and Proteomics to Develop Better Diagnostic Tools for Infectious Diseases. Abstracts. Int J Infect Dis. Cancún, 2004. p. 5.
  24. Kasper D, Tzianabos A, Comstock L. Use of Genomic Information to Develop Novel Ways of Preventing Complications of Infection. Abstracts. Int J Infect Dis. Cancún, 2004. p. 6.
  25. Normark S. The Bacterial Genome as a Plan for the Development of New Antibiotics. Abstracts. Int J Infect Dis. Cancún, 2004. p. 142.
  26. Rappuoli R, Covacci A. Using the Bacterial Genome to Study Pathogenesis. Abstracts. Int J Infect Dis. Cancún, 2004. p. 6.
  27. Graves P, Hyspead T. Molecular Biology Guide to Proteomes. Microbiol Mol Biol Review 2002;(66):39-63.
  28. Skultety L, Hernychova L, Kroca M, Stulik J, Macela A, Toman R. Proteomic Studies of Coxiella burnetii, the Etiological Agent of Q Fever. Abstracts. Int J Infect Dis. Cancún, 2004. p. 181.
  29. Jorgensen J, Crawford S, McElmeel L, Whitney C. Detection of Resistance to Newer Fluoroquinolones in Streptococcus pneumoniae by Testing with the VITEK 2 Instrument. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 170.
  30. Schwartz D, Wisniewski M, Xiang Y, Trick W, Weinstein R. Computer-Assisted Surveillance and Intervention for Needlessly Prolonged Vancomycin (V) Use. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 392.
  31. Allen A, Owen P, Lockyer M, Powell K, Burgis T, Corish P, et al. A General Method for the Identification of Essential genes in Bacteria. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 194.
  32. Cantón R. Using Flow Cytometry in Clinical Biology. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 448.
  33. Carey R. My Secret Life with Bacterial Antigen Testing. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 475.
  34. Peterson L, Hacek D, Noskin G. Fluoroqunolone use is Associated with an Increase in Vancomycin-Resistant Enterococci (VRE) Infections. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 320.
  35. Fantin B, Nicolau D. Technical Issues in Animal Models. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 468.
  36. Kuwahara K, Kitazawa T, Kitagaki H, Tsukamoto T, Kikuchi M. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes. J Dermatol Sci 2005;38(1):47-55.
  37. Calandra T. Innate Immune Responses Modulated by Macrophage Migration Inhibitory Factor. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 467.
  38. Akira S. Of Flies and Men: The Role of Toll-like Receptors in Innate Immunity. Abstracts. Int J Infect Dis. Cancún, 2004. p. 165.
  39. Mallal S. The Toxicogenomics of Abacavir Hypersensitivity. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 520.
  40. O?Mara E. Genetic Factors in Protease Inhibitor Hyperbilirubinemia. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 520.
  41. Rothschild J. Medication Errors: Epidemiology & Prevention. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 460.
  42. Goncales F, Silva C, Pereira J, Fais V, Pavan M, Escanhoela C, et al. Clinical, Pathological and Therapeutic Features in HCV-Chronic Infected Patients with Occult HBV Infection. Abstracts. Int J Infect Dis. Cancún, 2004. p. 120.
  43. Goncales N, Paula E, Xueref S, Carvalho M, Gilli S, Angerami R, et al. Prevalence and Epidemiological Characteristics of Transfusion-transmitted Infections among Multitransfused Patients in Campinas, Brazil. Abstracts. Int J Infect Dis. Cancún, 2004. p. 26.
  44. Boggild A, Axelrod E, Keystone J, Kain K. Parasitic and Vector-Borne Infections in Returned Canadian Travellers. Abstracts. Int J Infect Dis. Cancún, 2004. p. 25.
  45. Steffen R. Emergin Versus Traditional Infections and the Traveler. Abstracts. Int J Infect Dis. Cancún, 2004. p. 242.
  46. Ronald A. Travelers, Sexual Behavior, and Sexually Transmitted Infections. Abstracts. Int J Infect Dis. Cancún, 2004. p. 242.
  47. Galgiani J. The Valley Fever Vaccine Project, Current Status. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 471.
  48. Rapparini C, Fernandes G, Saraceni V, Machado A. Occupational Exposure to Blood-borne Pathogens in Brazil ? Implementation of a Surveillance System and a World-wide Web Discussion List. Abstracts. Int J Infect Dis. Cancún, 2004. p. 28.
  49. Sewell D. Laboratory Acquired Infections: Are Microbiologists at Risk?. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 507.
  50. Huertas M, Romero C, Ponce de León S, Sánchez G, Rangel S, González R. Risk for Blood-borne Transmitted Infections in Health Care Workers (HCWs): Results from an Ongoing Program. Abstracts. Int J Infect Dis. Cancún, 2004. p. 215.
  51. Martinov S, Chenchev I, Nedelchev N. African Horse Sickness Virus and Changes in the Species of the Genus ?Culicoides? in Bulgaria. Abstracts. 10th International Congress on Infectious Diseases. Singapur, 2002. p. 85.
  52. Hjelle B. Pathogenesis of Hantavirus Cardiopulmonary Syndrome. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 526.
  53. Khanna M, Henrickson K, Harrington K, Waters C, Meece J, Reed K, et al. Multiplex PCR-EHA Compared to ?Real Time? Taqman for the Surveillance and Diagnosis of West Nile Virus. Abstracts. Int J Infect Dis. Cancún, 2004. p. 40.
  54. Mourad A, Graham R, El-Wahab S, Bekheet M, Mahmoud T. Do Farm Chickens Have a Role in the Epidemiology of West Nile Virus?. Abstracts. Int J Infect Dis. Cancún, 2004. p. 191.
  55. Orenstein W. The Impact of Global Immunization Programs. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 451.
  56. Grishina L, Tulisov A, Gordienko T. Peculiarities of Diphtheria Epidemiology on the Background of Mass Vaccination in Arkhangelsk Region, Russia. Abstracts. International Journal of Infectious Diseases. Cancún, 2004. p. 107.
  57. Quiñones B, Franco R, Aguilar G, Codas R, Falcón M, Melgarejo N, et al. Brote Epidémico de Difteria en Paraguay. Abstracts. 3rd World Congress of Pediatric Infectious Diseases. Chile, 2002. p. 76.
  58. Roehrig J. Other Emerging Vector-Borne Viral Diseases. Abstracts. Int J Infect Dis. Cancún, 2004. p. 159.
  59. Puentes N, Aquino F, Márquez Y, Rojas J, Herrera M, Rodríguez A, et al. A Field Study of Venezuelan Equine Encephalitis (VEE) Entomological Surveillance in Sucre State, Venezuela. Abstracts. Int J Infect Dis. Cancún, 2004. p. 118.
  60. Chua K. Emergence of Nipah Virus: How it Happened! Will We Have Another Epidemic?. Abstracts. 10th International Congress on Infectious Diseases. Singapur, 2002. p. 64.
  61. Chua K. Nipah Virus: Bats to Pigs to Man. Abstracts. Int J Infect Dis. Cancún, 2004. p. 159.
  62. Zeller H. West Nile Virus Overview: Europe, the Middle East, and Northern Africa. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 527.
  63. Petersen L. Manifest Destiny? The Epidemiology of West Nile Virus in North America. Abstracts. Int J Infect Dis. Cancún, 2004. p. 159.
  64. Zingg N, Colombo C, Jucker T, Ruef C. Impact of a Norovirus Outbreak on Utilization of Hospital Resources. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 395.
  65. Gentile G, Capobianchi GA, Ferraironi E, Greco E, Martino P. Relationship of Serum Human Herpes Virus 6 (HHV-6)DNA with Cytomegalovirus (CMV) pp65 Antigenemia in Allogeneic Bone Marrow Transplant (BMT) Recipients. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 437.
  66. Sergerie Y, Boivin G. Evaluation of Human Herpesvirus 8 (HHV-8) Susceptibility to Antiviral Drugs by Quantitative Real-Time PCR. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 488.
  67. Xiao W. Epidemiology of Human Herpes Virus Eight in Hong Kong. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 438.
  68. Green M. PTLD in Transplant Patients: Management Strategies. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 517.
  69. Singh N. HHV-6 as a Pathogen in Transplant Patients: is it Time to Design Intervention Strategies. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 516.
  70. Petrola M, Naveda O, Febres O, Flores M, Escalona L, Castro L. Cytomegalovirus and Epstein Barr Virus Seroepidemiology in Valencia, Venezuela. Abstracts. 3rd World Congress of Pediatric Infectious Diseases. Chile, 2002. p. 94.
  71. Cecchini E, Agosti M, Greco M, Hertlein C, González S. Comparative Study of Acquired Cytomegalovirus (CMV) and Toxoplasma gondii Infections in Immunocompetent Hosts. Abstracts. Int J Infect Dis. Cancún, 2004. p. 110.
  72. Sampaio A, Bonon S, Patrocinio E, Soki M, Stucchi R, Costa F, et al. Detection and Monitorization of Active Cytomegalovirus (CMV) and Human Herpesvirus 6 (HHV-6) Infection by Antigenemia in Liver Transplantation Patients. Abstracts. Int J Infect Dis. Cancún, 2004. p. 44.
  73. Ziyaeyan Y, Sabahi F, Alborzi A, Mahboudi F, Karimi M, Pourabbas B, et al. A Specific and Sensitive PCR for Detection of HCMV DNA Using Novel gpB Primers. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 46.
  74. Bonon S, Rossi C, Souza C, Vigorito A, Costa S. CMV Infection Surveillance with Nested-PCR and Antigenemia Assays in Patients Who Received Or not Ganciclovir Universal Prophylaxis in HLA Identical Sibling Hematopoietic Stem Cell Transplants. Abstracts. Int J Infect Dis. Cancún, 2004. p. 125.
  75. Gentile G, Capobianchi A, Volpi A, Palu G, Pica F, Calistri A, et al. Human Herpesvirus 8 (HHV-8) Infection in Italian Allogeneic Bone Marrow Transplant (BMT) Recipients. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 438.
  76. Lee H. Adenoviral Lower Respiratory Tract Infections. Abstracts. 3rd World Congress of Pediatric Infectious Diseases. Chile, 2002. p. 25.
  77. Umrido V, Bakir J, Romanin V, Ruttimann R, Mistchenko A, Gentile A. Clinic-Epidemiological Pattern (CP) of Adenovirus Infection in a Pediatric Hospital. Abstracts. Int J Infect Dis. Cancún, 2004. p. 62.
  78. Chung E, Chang H, Lee J, Kim N, Choi E, Lee H. Seroepidemiologic Study of Adenoviral Infection in Korea. Abstracts. Int J Infect Dis. Cancún, 2004. p. 124.
  79. Kroes A, Lankester A, Claas E, Vossen J, Van Tol M. Adenovirus and Stem Cell Transplantation: Epidemiologym Clinical Relevance and Approaches to Management. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 441.
  80. Lion T. Diagnosis of Adenovirus Infections in Transplant Recipients. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 516.
  81. Hawksworth A, Irvine M, Russel K, Ryan M, Strickler J, Gaydos J, et al. Recurrent Epidemics of Adenoviral Respiratory Illness among US Military Recruits in the Absence of Oral Vaccines. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 429.
  82. Gottuzzo E. A Hidden Epidemic: The HTLV-1 Story in Latin America. Abstracts. Int J Infect Dis. Cancún, 2004. p. 165.
  83. Das S. Screening for Human T Cell Leukaemia Virus Type I among Myelopathy/Tropical Spastic Paraparesis Cases in and around Kolkata. Abstracts. 10th International Congress on Infectious Diseases. Singapur, 2002. p.
  84. Prokopowicz D, Wiercinska A, Tarasow E. Cerebral Magnetic Resonance Spectroscopy in Neurologically Asymptomatic HIV-infected Patients. Abstracts. 10th International Congress on Infectious Diseases. Singapur, 2002. p. 159.
  85. Kooyk Y. Early Events in HIV Infection. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 467.
  86. Hahn B, Shaw G, De Cock K, Sharp P. AIDS as a Zoonosis: Scientific and Public Health Implications. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 525.
  87. Quinn T. The Global Epidemiology of HIV Genetic Subtypes. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 467.
  88. Alvarez A, Molina R, Pérez J. HLA Class I Alleles Associated with Human Immunodeficiency Virus Type 1 Infection among Cuban Population. Abstracts. Int J Infect Dis. Cancún, 2004. p. 34.
  89. Palma A, Lara W, López M. Genotype CCCR5, is a Protective Factor for the Transmission of the HIV in Children. Abstracts. Int J Infect Dis. Cancún, 2004. p. 35.
  90. Gulick R. Recent Advances in Clinical Management of the Antiretroviral Naïve Patient. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 518.
  91. Witmer M, Parkin N, Petropoulos C, Donovich R, Shcleif W, Gabryelski L, et al. Integrase from HIV-1 Patient Isolates Exhibit Minimal Differences in Susceptibility to Inhibitors in Vitro. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 320.
  92. Beran O, Holub M, Hnykova J, Rozsypal H, Spala J. Expression of CD38 Antigen on CD8+ T Lymphocytes in HIV-1-Infected Adults: The Czech Prospective Study. Abstracts. Int J Infect Dis. Cancún, 2004. p. 33.
  93. Robertson M. HIV: Ongoing Development and Evaluation of a Potential HIV-1 Vaccine Using a Replication-Defective Adenoviral Vector. Abstracts. Int J Infect Dis. Cancún, 2004. p. 85.
  94. Deibis L. Diagnóstico de Laboratorio de la Infección por VIH en la Epoca Actual. Resúmenes del XI Congreso Venezolano de Bioanálisis. Caracas, junio 2004.
  95. Holm H, Haugen I, Stjerholm G, Lindahl G, Sannes M, Sorensen B, et al. Antibodies to HIV Can be Detected in Air-dried Saliva. Abstracts. 10th International Congress on Infectious Diseases. Singapur, 2002. p. 93.
  96. Marini M, Fischer H, De Lisi N, Lovaglio M, Di Lorenzo O. Empleo de la Modificación de los Valores IgG como Criterio de Orientación en el Diagnóstico de la Infección por HIV. Abstracts. 3rd World Congress of Pediatric Infectious Diseases. Chile, 2002. P. 51.
  97. Thomas D. Hepatitis C. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 536.
  98. Thomas D. Hepatitis C in the HIV Infected Patient. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 472.
  99. Rockstroh J. Management of Co-Infected Patients. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 448.
  100. Hoffman M, Kimmel S, O?Donnel E, Kleinman L. Correlation Between Surrogate Markers and Degree of Biopsy-Proven Liver Damage in HIV/HC Coinfected Patients. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 432.
  101. Roca B, Suarez I, González J, Garrido M, García M, Teira R, et al. Epidemiology of HIV and HCV Coinfection in Spain. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 425.
  102. Sande M, Gilbert D, Moellering R. The Sandford Guide to HIV/AIDS Therapy. 2002. 11th Edition. USA. Antimicrobial Therapy Inc. 2002.
  103. Mago H, Rocha R, Querales E, Aguilar L, Martínez E, Vitale M. Prevalence of Antibodies against Opportunistic Infections in HIV Infected Patients Assisting to a Venezuelan Hospital. Abstracts. Int J Infect Dis. Cancún, 2004. p. 207.
  104. Kouri V, Rodríguez M, Infante E, Capo V, Reslik S, Tenorio A, et al. Kaposi?s Sarcoma-associated Herpes Virus (kshv) and Kaposi?s Sarcoma (ks) in Cuba. Abstracts. International Journal of Infectious Diseases. Cancún, 2004. p. 202.
  105. Hernández D, Masquelier B, Pérez O, Oliver M, Fleury H. Human Herpesvirus 8 Variants in Venezuelan Patients with AIDS-Related Kaposi Sarcoma. CID 2003;36:385-6.
  106. Luke A Li H, Demeter L, Reichman R. Effect of Highly Active Antiretroviral Therapy (HAART) on Human Papilomavirus (HPV) Infection and Disease among HIV-Infected Women. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 255.
  107. King M, Reznik D, O?Daniels C, Larsen N, Blumberg H. Emergence of Oral Human Papillomavirus (HPV) Infection among HIV-seropositive Patients. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 255.
  108. Cintra O, Rocha G, Cervi M, Macedo I, Chunha C, Andrade T, et al. Frequency and Severity of Respiratory Syncytial Virus (RSV) Infections in Children with AID and Lower Respiratory Tract Infections. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 428.
  109. Scarpellini P, Carrera P, Cavallero A, Cedri M, Cernuschi M, Ferrari M, et al. Rapid Detection of Helicobacter pylori Resistance to Charithromycin (CLA) by Double Gradient-Denaturing Gradient Gel Electrophoresis (DG-DGGE) from Gastric Biopsies of HIV Infected (HIV +) patients. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 149.
  110. Meenken G, Van Den Horn G. Ocular Disease as the First Symptom of Syphilis in HIV. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 499.
  111. Andrade RE, Marcano MJ. Infecciones Bacterianas en Pacientes con VIH/SIDA. Infor Med 2003:5(5):155-76.
  112. Marcano M, Urrestarazu M, Serrano N. Helicobacter pylori en Dermatología. Breve Revisión de la Literatura. Derm Venz 2003:41(2):3-7.
  113. Marcano L MJ, Andrade RE, Landaeta JM, Montes de Oca J. Infecciones bacterianas asociadas al VIH/SIDA. VITAE disponible en: http://caibco.ucv.ve/Vitae/VitaeDiecisiete/Articulos/Infectologia/ArchivosHTML/Introduccion.htm
  114. Manfredi R, Calza L, Chiodo F. Enterococci and HIV Infection: Features and Evolution of an Unexpectedly Common Disease Association. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 343.
  115. Della Negra M, Queiroz W, Lian Y, Pochini A, Neto C, Pacola D. Managing Opportunistic Infections and HIV Complications in Low-resource Settings. Abstracts. Int J Infect Dis. Cancún, 2004. p. 23.
  116. Andrade P RE, Marcano L MJ, Infecciones parasitarias en el paciente infectado por el virus de la inmunodeficiencia humana: aspectos etiológicos. clínicos, diagnósticos, terapéuticos y profilaxis. Rev Soc Ven Microbiol 2003;23(2):169-74.
  117. Olariu T, Koreck A, Iacobiciu I, Petrescu C. Strongyloidiasis in HIV-infected Children. Abstracts. Int J Infect Dis. Cancún, 2004. p. 205.
  118. Phillips P. Aspergillosis in AIDS: Improved Survival with Highly Active Antiretroviral Therapy (HAART). Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 377.
  119. Vázquez J, Northland R, Miller S, Dickinson G, Wright G. Posaconazole Compared to Fluconazole for OralCandidiasis in HIV-Positive Patients. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 372.
  120. O?Daniels C, Larsen N, Reznik D, Ramírez M, Drouin T, Lennox J, et al. Prevalence and Risk Factors of Candida dubliniensis in Oral Candidiasis (OC) Among HIV-Seropositive Patients. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 382.
  121. Perea S, López J, Kirkpatrick W, Bachmann S, Martínez M, Patterson T. Molecular Mechanisms of Azole Resistance in Clinical Isolates of C. dubliniensis from HIV-Patients with Oropharyngeal Candidiasis (OPC). 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 393.
  122. McGowan O, Garofalo L, Kim J, Blecker D. Retrospective Identification of Candida dubliniensis Isolates Among Candida albicans Clinical Laboratory Isolates From Pediatric Patients Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 399.
  123. Singh N, Linden P, Muñoz P, Domínguez E, Kusne S, Snydman D, et al. Emerging Trends in Invasive Mold Infections in Organ Transplant Recipients. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 376.
  124. Singh N, Paterson D, Gayowski T, Marino I, Wagener M. Pre-emptive Prophylaxis with Lipid Preparation of Amphotericin B (AmB) for Invasive Fungal Infections in Liver Transplant Recipients Requiring Dialysis. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 381.
  125. Atzori C, Valerio A, Troconi E, Fantoni G, Cargnel A. P. carinii: Lack of Correlation between DHPS Mutations and ITSs Genotypes. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 399.
  126. Tamayo J. La Patología del SIDA. En el texto: Avances en Patología. Cabildo de Fuerte Ventura. Servicio de Publicaciones. Instituto de Investigación y Ciencias Fuerte Ventura. Islas Canarias. 1996:153-63.
  127. Losada C, Mago H, Gómez F. Epidemiological Findings and Prevalence of Antibodies against Agents of Endemic Reactivable Mycosis in Patients with HIV in Valencia. Venezuela. Abstracts. Int J Infect Dis. Cancún, 2004. p. 207.
  128. Long E, Ebrahimzadeh A, White E, Swisher B, Callaway C. Alga Associate with Diarrhea in Patients with Acquired Immunodefficiency Syndrome and in Travelers. J Clin Biol 1990;28(6):1101-4.
  129. Kaminski ZC, Kapila R, Sharer LR, Kloser P, Kaufman L. Meningitis due to Prototheca wickerhamii in a Patient with AIDS. Clin Infect Dis 1992;15(4):704-6.
  130. López E. Hepatitis A: Outbreaks and Implications for Future Vaccine Strategies. Abstracts. International Journal of Infectious Diseases. Cancún, 2004. p. 80.
  131. Ristevska J, Malevska V, Jovanovic L, Balalovski D, Galovska D, Petkovska R, et al. E. Virus Hepatitis ?A? and Associated Diseases and Conditions. Abstracts. Int J Infect Dis. Cancún, 2004. Pag. 156.
  132. Rodrigues L, Peneda J, Barreiro P, Alvim M, Agua I, Ferreira C. Hepatitis B Virus Genotypes and Core Promotor and Precore Mutations in Chronic Hepatitis B. Abstracts. Int J Infect Dis. Cancún, 2004. p. 153.
  133. Evtmovska C, Dimitriev D, Gaseva M, Ivanovska J, Grunevska V Dimzova M, et al. Etiological Aspects of Chronic Viral Hepatitis. Abstracts. Int J Infect Dis. Cancún, 2004. p. 155.
  134. Juárez L, Casales R, Uribe F, Conde C, Olaiz G. Socio-economic Characteristics Associated to Hepatitis B Virus Transmission in the States with Increased Anti-HBc Seroprevalence in Mexico. Abstracts. Int J Infect Dis. Cancún, 2004. p. 121.
  135. Grumvska V, Ivanovski L, Dimitriev D, Gaseva M, Nasteska C, Grozdanovski K, et al. Seroprevalence of HBV Markers among Anti HCV Positive I.V. Drug Users. Abstracts. Int J Infect Dis. Cancún, 2004. p. 121.
  136. Colonno R, Weinheimer S, Rose R, Levine S., Discotto L, Plym M, et al. Emerging Amino Acid Substitutions in Lamivudine-Resistant HBV that Result in Reduced Susceptibility to Entecavir. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 497.
  137. Lagares D. Hepatitis B Markers in Adults from Africa. Abstracts. Int J Infect Dis. Cancún, 2004. p. 156.
  138. Rosen H. Pathogenesis of Hepatitis C. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 472.
  139. Goldberg D. HCV Transmission in Prisons: How Much, How Do We Stop It?. Abstracts. International Journal of Infectious Diseases. Cancún, 2004. p. 4.
  140. Kamceva M, Kamcev N, Vitlarova J, Siskova D, Karagjozova G, Ikonomova L. Transmission of Hepatitis C Virus Infection Between Marital Partners During Sexual and Home Contact ? Our Experience. Abstracts. Int J Infect Dis. Cancún, 2004. p. 151.
  141. Bossi G, Maccabruni A, Martinetti M, Salvaneschi L, Salati B, Minola E. Hierarchy of Baby-linked Immunogenetic Risk Factors in the Vertical Transmission of Hepatitis C Virus. Abstracts. Int J Infect Dis. Cancún, 2004. p. 155.
  142. Oshima K, Shouda A, Okazaki T, Tada K, Nishikawa M, et al. Clinical Significance of HCV Vertical Transmission. Abstracts. Int J Infect Dis. Cancún, 2004. p. 156.
  143. Maccabruni A, Minola E, Bossi G, Sutter F, Lazzaroni C, Salati B. Late Clearance of Viremia in One Perinatally HCV HCV-Infected Child: Should The Concept of HCV Infection Chronicity be Revised in Pediatric Patients. Abstracts. Int J Infect Dis. Cancún, 2004. p. 157.
  144. De Cock L, Hutse V, Verhaegen E, Quolin S, Vandenbergue H, Vranckx R. Detection of HCV Antibodies in Oral Fluid. Abstracts. Int J Infect Dis. Cancún, 2004. p. 156.
  145. Region During Interferon Therapy with or without Ribavirin. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 496.
  146. Lagares D, Mora J. Hepatitis C in African Immigrants. Abstracts. Int J Infect Dis. Cancún, 2004. p. 157.
  147. Perella O, D?Antonio A, Guarnaccia D, Bellopede P, Desena R, Ascione T, et al. Is There a Role for BcL2 Proteins for Hepatocellular Carcinoma?. Abstracts. Int J Infect Dis. Cancún, 2004. p. 39.
  148. Avonts D, Baay M, Verhoeven V, Weyler J, Lardon F, Royen P, et al. The Association Between Genital Infections with Chlamydia trachomatis and Human Papilomavirus is independent of Sexual Behaviour. Abstracts. Int J Infect Dis. Cancún, 2004. p. 66.
  149. Takahashi S, Kunishima Y, Shimizu T, Takeyama K, Hotta H, Tsukamoto T, et al. Risk Factors for HPV Infection of the Male External Genitalia. Abstracts. 10th International Congress on Infectious Diseases. Singapur, 2002. p. 90.
  150. Finan R, Tamim H, Rashid M, Sharida H, Irani N, Almawi W. Molecular Detection and Genotyping of Human Papillomavirus (HPV) in Cervical Samples from Women with Normal and Abnormal Cytology. Abstracts. Int J Infect Dis. Cancún, 2004. p. 66.
  151. Peralta O, Bermúdez V, Bahena M, Alcocer J, Recillas F, Madrid V. The Immunosupressor Cytokine TGF-beta-1 is Regulated by HPV-16 E6 and E7 Oncoproteins in Cervical Cancer. Abstracts. Int J Infect Dis. Cancún, 2004. p. 42.
  152. Muñoz N. Human Papillomavirus: Rationale for the Introduction of Human Papillomavirus Vaccines in the Prevention of Cervical Cancer. Abstracts. Int J Infect Dis. Cancún, 2004. p. 3.
  153. Cáceres B. Virus Respiratorios. Resúmenes del XI Congreso Venezolano de Bioanálisis. Caracas, junio 2004.
  154. Welliver R, Jackson H, Huson L, Ward P. The Increased Risk of Transmission of Influenza in the Family Setting. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 481.
  155. Subbaroo K. Virulence of Influenza: Lessons from Past Outbreaks. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 462.
  156. Nichol K. Influenza. A Persistent Plague for Humankind. Abstracts. Int J Infect Dis. Cancún, 2004. p. 79.
  157. Viboud C, Miller M. Spatial and temporal spread of influenza epidemics in the United States: 1968-1998. Abstracts. Int J Infect Dis. Cancún, 2004. p. 126.
  158. Flahault A, Viboud C. Association of Influenza Excess Deaths in France and the USA with Global Climate Variability. Abstracts. Int J Infect Dis. Cancún, 2004. p.125.
  159. Van der Sluijs K, Van Elden L, Nijhuis M, Schuurman R, Florquin S, Jansen H, et al. Toll-Like Receptor 4 is not Involved in Host Defense against Respiratory Tract Infection with Influenza or Parainfluenza Virus. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p.430.
  160. Gravenstein S, Freund B, McElhaney J, Peters P, Von Planta T, Ward P. Complications of and Risk Factors for Influenza. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 481.
  161. Keller T, Mairuhu A, Gerdes V, Meijers J, Osterhaus A, Gorp E, et al. Do Naturally Occurring Influenza Infections result in Prothrombotic State? Report from a Pilot Study. Abstracts. Int J Infect Dis. Cancún, 2004. p. 38.
  162. Eich C, Eich G, Krause M. Rhabdomyolysis in Influenza-like Illness as a Marker for Infection by Influenza A or B Virus. Abstracts. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. Toronto, 2000. p. 481.
  163. Togashi T, Matsuzono Y, Morishima T, Narita M. Influenza-Associated Encephalopathy in Japanese Children. Abstracts. 3rd World Congress of Pediatric Infectious Diseases. Chile, 2002. p. 92.
  164. Oropesa S, Acosta B, Pinon A, Hernández B. Monoclonal Antibodies for Type and Subtype Specific detection of Influenza Viruses in Clinical Specimens by Rapid Culture Assay. Int J Infect Dis. Cancún, 2004. p. 48.
  165. Esposito S, Marchisio P, Morelli P, Bosis S, Lambertini L, Claut L, et al. Effect of Rapid Diagnostic Tests for Influenza on the Emergency Department. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 428.
  166. Uyeki T. Rapid Influenza Diagnostic Tests. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 462.
  167. Abed Y, Goyette N, Boiving G. Generation and Characterization of recombinant Influenza A Virus Mutants Resistant to Neuraminidase Inhibitors and Amantadine. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 492.
  168. Carr J, Roberts N, Covington E. Oseltamivir Phosphate in a Clinical Setting does not Select Resistant Mutations in Influenza Virus Haemagglutinnin. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 431.
  169. Bagnulo H, Velázquez A, Dibarboure H, García A, Arnoux S, Sosa B, et al. Sentinel Study Influenza Virus in Montevideo, Uruguay, 1995-2003. Abstracts. Int J Infect Dis. Cancún, 2004. p. 235.
  170. Bakir J, Umido V, Romanin V, Ruttiman R, Viegas M, Mistchenko A, et al. Clinic-epidemiological Pattern (CP) of Influenza Infection in a Pediatric Hospital. Abstracts. Int J Infect Dis. Cancún, 2004. p. 62.
  171. Modlin L. Universal Childhood Immunization Against Influenza. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 462.
  172. Brydak L, Machala M, Laguna P, Milewska R. Hemagglutinin Antibody Kinetics in Spenectomized Patients Vaccinated against Influenza. Abstracts. Int J Infect Dis. Cancún, 2004. p. 72.
  173. Devincenzo J, Harrison L, Aitken J. Opportunities for Early Therapy of Respiratory Syncytial Virus (RSV) Infection: What Happens Before Hospitalization. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 428.
  174. Valdes O, Savon C, Goyenechea A, Valdevia A, González G, Palerm L, et al. Genetic Diversity and Molecular Epidemiology of Respiratory Syncytial Virus Over Six Consecutive Seasons in Cuba. Abstracts. Int J Infect Dis. Cancún, 2004. p. 123.
  175. Devincenzo J, Piedra P. Prevention and Management of RSV Infection. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 464.
  176. Mortensen J, Ventrola C, Denys G, Leland D, Nelson R, North P, et al. A Multicenter Evaluation of the Performance of the Rapid OIA Test for the Detection Of Respiratory Syncytial Virus Antigen. Abstracts. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, 2003. p. 428.
  177. Crowe J, Williams J. Metapneumovirus Infections in Infants and Children. Abstracts. ASM?s Annual Meeting on Infectious Disease. Chicago, 2003. p. 522.
  178. Rota P. Characterization of a Novel Coronavirus Causing Severe Acute Respiratory Syndrome. Abstracts. Int J Infect Dis. Cancún, 2004. p. 158.
  179. Vijgen L, Keyaerts E, Duson G, Neyts J, Ranst M. Absolute Quantification of SARS-associated Coronavirus RNA Using a Real-time Quantitative RT-PCR. Abstracts. Int J Infect Dis. Cancún, 2004. p. 43.
  180. Wenzel R. Lessons from the SARS Epidemic. Abstracts. Int J Infect Dis. Cancún, 2004. p. 77.
  181. McIntosh K. Virology and Pathogenesis of Coronavirus. Abstracts. Int J Infect Dis. Cancún, 2004. p. 158.
  182. Gomersall C, Joynt G, La
Introducción
Infecciones Respiratorias
Infecciones Diarreicas
Infecciones Hemorrágicas
Infecciones Nosocomiales
Infecciones por Estreptococos
Infecciones Micóticas
Infecciones Parasitarias
Misceláneos
Situaciones Especiales
Referencias

NOTA: Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.





Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO,
caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit